Airway Stents (General Surgery) - Global Market Analysis and Forecast Model
Summary Airway Stents (General Surgery) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within General Surgery therapeutic area.
Airway Stents are a hollow tube shaped device which is inserted into an airway to relieve obstruction.It is also known as a tracheobronchial stent.
Silicone airway stents and metallic airway stents are covered under this segment. The airway stents market is driven by a wide variety of factors; however the market is primarily driven by the increase in the aging population, the increase in patients with benign disease, benign tracheoesophageal fistula and airway stenosis.
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes.To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available).
Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model
Currently marketed Airway Stents and evolving competitive landscape - - Insightful review of the key industry trends. - Annualized total Airway Stents market revenue by segment and market outlooks from 2015-2028. - Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights - - Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market. - SWOT analysis for this Airway Stents market. - Competitive dynamics insights and trends provided for this Airway Stents market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape. - Country specific overview of the healthcare system. - Country specific reimbursement policies. - Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market.Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders.
In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Scientific Corp, Getinge AB, Merit Medical Systems, Inc., Novatech SA, Cook Group Inc, Micro-Tech (Nanjing) Co Ltd, Leufen Medical GmbH, Taewoong Medical Co.,Ltd., Stening SRL
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Scope This Market Model gives important, expert insight you won’t find in any other source.
The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for - - CMO executives who must have deep understanding of the Airway Stents marketplace to make strategic planning and investment decisions. - Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. - Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to buy The model will enable you to - - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the Airway Stents market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Airway Stents market in the future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Track device sales in the global and country-specific the Airway Stents market from 2015-2028. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Our reports have been used by over 10K customers, including:
Global Molecular Diagnostic Point of Care Market to Reach $6.02 Billion by 2029 Key Questions Answered in this Report: • What are the major market drivers, challenges, and opportunities in the global molecular diagnostic point of care market? • What are the factors resulting in the emerging...
Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Freestyle Lite, True Metrix), And Segment Forecasts, 2019 - 2025 The global point-of-care glucose testing market size recorded a revenue of USD 6,017.83 million in 2018 and is expected...
Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, “Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiac Markers Rapid Tests & Point of Care...
141 pages •
By Global Industry Analysts
• Oct 2019
Case Management market worldwide is projected to grow by US$4.4 Billion, driven by a compounded growth of 9.3%. Solution, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing...
Healthcare Provider Network Management market worldwide is projected to grow by US$2.3 Billion, driven by a compounded growth of 10.3%. Services, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to...
The report on the global mycotoxin binders market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global mycotoxin binders market to grow with a CAGR of 5.3% over the forecast period from 2019-2025. The study on mycotoxin binders market covers the analysis of...
224 pages •
By Global Industry Analysts
• Oct 2019
Care Management Solutions market worldwide is projected to grow by US$16.9 Billion, driven by a compounded growth of 16.5%. Disease Management, one of the segments analyzed and sized in this study, displays the potential to grow at over 17.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep...
152 pages •
By Global Industry Analysts
• Oct 2019
Specialty Medical Chairs market worldwide is projected to grow by US$2.6 Billion, driven by a compounded growth of 6.4%. Examination Chairs, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast...
This IDC Perspective provides insights into AHIP Institute's 2019 conference."The AHIP Institute 2019 conference showed how consumerism, big data, whole-person coordinated care, social determinants of health, and innovation are indeed now embedded in successful payers. Presented technology showed how payers are moving proactively on multiple...
Global Public Health Partnering 2014 to 2019 provides the full collection of Public Health disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Public Health partnering deals Financial deal terms for headline, upfront and royalty by stage of development Public...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.